Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.37 +0.07 (+0.46%)
Streaming Delayed Price Updated: 11:09 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
AUPH INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation – AUPH
From Rosen Law Firm
Via Business Wire
News headline image
Cramer Shares His Thoughts On PubMatic, Aurinia Pharmaceuticals And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although Kulicke and Soffa Industries, Inc. 
Via Benzinga
News headline image
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook ↗
The company expects 150%-200% growth in its key product. But that wasn't enough. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For February 28, 2022 ↗
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation AUPH
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗
Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri... 
Via Benzinga
News headline image
Expert Ratings For Aurinia Pharmaceuticals ↗
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed... 
Via Benzinga
News headline image
67 Biggest Movers From Yesterday ↗
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack... 
Via Benzinga
News headline image
42 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group... 
Via Benzinga
News headline image
Stocks Mixed as Investors Weigh Sanctions ↗
U.S. markets have cut a great deal of this morning's losses, though the Dow Jones Industrial Average (DJI) is still down 
Via Talk Markets
News headline image
Why Aurinia Pharmaceuticals Shares Are Falling Today ↗
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis.... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict ↗
U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia. Following the market opening... 
Via Benzinga
News headline image
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis ↗
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information... 
Via Benzinga
News headline image
Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors ↗
Aurinia Pharma popped after Novartis said it's focused on bolt-on deals. 
Via Investor's Business Daily
News headline image
EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today ↗
Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report. 
Via InvestorPlace
News headline image
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today ↗
Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office. 
Via InvestorPlace
Topics Intellectual Property
News headline image
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today ↗
Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS). 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.